[Pharmacokinetics and metabolite spectrum of glisoxepide in humans].
D000328:Adult; D000368:Aged; D001381:Azepines / Q000378:metabolism*; D002245:Carbon Dioxide / Q000378:metabolism; D002250:Carbon Radioisotopes; D002845:Chromatography; D003920:Diabetes Mellitus / Q000378:metabolism; D004341:Drug Evaluation; D005243:Feces / Q000032:analysis; D005260:Female; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000378:metabolism*; D013056:Spectrophotometry, Ultraviolet; D013453:Sulfonylurea Compounds / Q000378:metabolism*; D013462:Sulfur Radioisotopes; D014316:Tritium
D001381:Azepines; D002250:Carbon Radioisotopes; D007004:Hypoglycemic Agents; D010080:Oxazoles; D013453:Sulfonylurea Compounds; D013462:Sulfur Radioisotopes; D014316:Tritium; D002245:Carbon Dioxide
Pharmakokinetik und Metabolitenspektrum von Glisoxepid beim Menschen